MOCA-Funded Research

Research

MOCA is a national leader in ovarian cancer research funding. Because of you.

Research

MOCA. A leader in ovarian cancer research funding. Because of you.

MOCA is a national leader among private, non-profit organizations.

MOCA has awarded more than $9 million in grants to professional researchers investigating various aspects of ovarian, fallopian and primary peritoneal cancer.

Every dollar directed to research means we’re getting closer to an early detection test, better treatments and, one day, a cure for ovarian cancer.

MOCA’s Research Funding

Since MOCA started funding research in 2001, MOCA has provided funding to more than 100 grants focused on ovarian cancer. We fund innovative research projects – based in Minnesota – that will help develop better treatments, an early detection test and a cure for ovarian cancer.

In an effort to continue our push for an early detection test for ovarian cancer, in 2017 MOCA launched our National Early Detection Research Awards. Each year, we provide funding to researchers outside Minnesota who are committed to the work of developing an early detection test for ovarian cancer.

Each year, a panel of national expert reviewers help advise MOCA on the scientific merit and national significance of each research proposal. A group of consumer advocates, made up of survivors and caregivers, also review our grants to ensure we are funding research that is most likely to have the biggest impact on our community.

If you would like to learn more about MOCA’s research funding efforts, contact MOCA Executive Director Kathleen Gavin at kgavin@mnovarian.org.

Hear from our researchers

MOCA’s research funding is vital to getting these promising projects off the ground. Hear it from the researchers themselves.

Bruce Walcheck, Ph.D.

University of Minnesota

Bruce Walcheck, Ph.D.

“Research is absolutely necessary for better diagnostics and treatments for ovarian cancer. MOCA uses a rigorous process to determine the research it is going to invest in. We’ll use our funding to help accomplish the mission.”

Martina Bazzaro, Ph.D.

University of Minnesota

Martina Bazzaro, Ph.D.

“The research funding from MOCA gives me the freedom to test new ideas that are outside the box – with the goal of truly making a difference for women with ovarian cancer.”

Viji Shridhar, Ph.D.

Mayo Clinic

Viji Shridhar, Ph.D.

“The grants from MOCA have served as a platform to generate critical preliminary data that I’ve leveraged into federal grants from the National Institute of Health and the Department of Defense”

Kevin Elias, M.D.

Harvard Medical School

Kevin Elias, MD

“Ovarian cancer research is driven by advocacy and philanthropy much more than federal funding. Without the support of advocates, this work would not happen. Your work keeps me going!”

2020 MOCA-FUNDED Research

MOCA awarded $400,000 to ovarian cancer research projects on November 19, 2020, putting our total amount of ovarian cancer research funding at more than $9 million. Learn more about MOCA’s 2020 Research Awards from the researchers themselves. Watch our Research Awards program.

The 2020 MOCA-funded researchers include:

Matthew Block, M.D., Ph.D., Mayo Clinic, “Restructuring the ovarian cancer immune microenvironment with the heparan sulfate mimetic PG545.” $100,000 for one year. This award is funded in part by MOCA’s Spin it Teal Research Award.
Amy Skubitz, Ph.D., University of Minnesota, “Early detection of ovarian cancer.” National Early Detection Research Award, $100,000 for one year. This award is funded in part by the Molly Cade Research Grant.
Vijayalakshmi Shridhar, Ph.D., Mayo Clinic, “Quinacrine-induced active Cathepsin L is essential to promote ‘BRCAness’ to sensitize HR proficient ovarian cancer cells to PARP inhibitor.” $100,000 for one year.
Daniel Vallera, Ph.D., University of Minnesota, “Engaging the immune system against ovarian cancer.” $100,000 for one year.

MOCA’s past research funding awards listing.

Impact of MOCA-Funded Research